LP220255-6
Edoxaban
Active
Description
Edoxaban (DU-176b, trade names Savaysa, Lixiana) is an oral anticoagulant drug that acts as a direct factor Xa inhibitor, by selectively inhibiting free factor Xa in the coagulation cascade, resulting in reduced thrombin generation. Edoxaban is used for the prevention of stroke and non-central-nervous-system systemic embolism in patients with non-valvular atrial fibrillation. The FDA also approved edoxaban for treating deep vein thrombosis and pulmonary embolism in patients who have been treated with a parenteral anticoagulant for 5 to 10 days. Source: LOINC partner 1
Basic Part Properties
- Part Name
- Edoxaban
- Part Display Name
- Edoxaban
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2016-06-24
- Construct for LOINC Short Name
- Edoxaban
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 依度沙班 Synonyms: 伊多塞班; |
| es-ES | Spanish (Spain) | Edoxaban |
| it-IT | Italian (Italy) | Edoxaban |
| fr-FR | French (France) | Édoxaban |
| el-GR | Greek (Greece) | Εδοξαμπάνη Synonyms: Εδοξαμπάνη |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://